{'output': [['Bristol-Myers Squibb', 'COMP', 'Record', '$3 billion charge', 'ECON_INDICATOR'], ['Bristol-Myers Squibb', 'COMP', 'Relate_To', 'U.S. tax reform law', 'ORG/GOV'], ['Bristol-Myers Squibb', 'COMP', 'Announce', 'Regulatory filing', 'ORG/REG'], ['$3 billion charge', 'ECON_INDICATOR', 'Impact', 'Bristol-Myers Squibb', 'COMP'], ['$3 billion charge', 'ECON_INDICATOR', 'Relate_To', 'Unremitted offshore earnings', 'CONCEPT'], ['Bristol-Myers Squibb', 'COMP', 'Affect', 'Previous forecast for net earnings per share', 'ECON_INDICATOR'], ['Bristol-Myers Squibb', 'COMP', 'Affect', 'Tax rate', 'ECON_INDICATOR'], ['Bristol-Myers Squibb', 'COMP', 'Operate_In', 'Pharmaceutical industry', 'SECTOR'], ['U.S. tax reform law', 'ORG/GOV', 'Change', 'Corporate income tax rate', 'ECON_INDICATOR'], ['U.S. tax reform law', 'ORG/GOV', 'Exempt', 'U.S. corporations from U.S. taxes on most future foreign profits', 'CONCEPT'], ['U.S. tax reform law', 'ORG/GOV', 'Set', 'One-time tax for U.S. business profits now held overseas', 'CONCEPT'], ['U.S. tax reform law', 'ORG/GOV', 'Prevent', 'Companies from shifting profits out of the United States to lower-tax jurisdictions abroad', 'CONCEPT'], ['Bristol-Myers Squibb', 'COMP', 'Estimate', 'Neutral impact on adjusted tax rate', 'ECON_INDICATOR'], ['Bristol-Myers Squibb', 'COMP', 'Plan', 'Update on Feb. 5', 'DATE']]}